Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 334

1.

Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.

Knops RE, Olde Nordkamp LR, de Groot JR, Wilde AA.

Heart Rhythm. 2013 Aug;10(8):1240-3. doi: 10.1016/j.hrthm.2013.05.016. Epub 2013 May 21.

PMID:
23707489
2.

Intermuscular Two-Incision Technique for Subcutaneous Implantable Cardioverter Defibrillator Implantation: Results from a Multicenter Registry.

Migliore F, Allocca G, Calzolari V, Crosato M, Facchin D, Daleffe E, Zecchin M, Fantinel M, Cannas S, Arancio R, Marchese P, Zanon F, Zorzi A, Iliceto S, Bertaglia E.

Pacing Clin Electrophysiol. 2017 Mar;40(3):278-285. doi: 10.1111/pace.12987. Epub 2017 Feb 10.

PMID:
27943358
3.

Implantable transvenous cardioverter-defibrillators.

Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D.

Circulation. 1993 Apr;87(4):1152-68.

PMID:
8462144
4.

Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.

Essandoh MK, Portillo JG, Weiss R, Otey AJ, Zuleta-Alarcon AN, Humeidan ML, Torres JL, Flores AS, Castellon-Larios K, Abdel-Rasoul M, Andritsos MJ, Perez WJ, Stein EJ, Turner KR, Dimitrova GT, Awad H, Bhandary SP, Tripathi RS, Joseph NC, Hummel JD, Augostini RS, Kalbfleisch SJ, Tyler JD, Houmsse M, Daoud EG.

J Clin Anesth. 2016 Jun;31:53-9. doi: 10.1016/j.jclinane.2015.11.009. Epub 2016 Mar 22.

PMID:
27185678
5.

The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE.

J Am Coll Cardiol. 2012 Nov 6;60(19):1933-9. doi: 10.1016/j.jacc.2012.06.053. Epub 2012 Oct 10.

7.

Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation Techniques.

Brouwer TF, Miller MA, Quast AB, Palaniswamy C, Dukkipati SR, Reddy V, Wilde AA, Willner JM, Knops RE.

Circ Arrhythm Electrophysiol. 2017 Jan;10(1):e004663. doi: 10.1161/CIRCEP.116.004663.

PMID:
28073910
8.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.

9.

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.

Kooiman KM, Knops RE, Olde Nordkamp L, Wilde AA, de Groot JR.

Heart Rhythm. 2014 Mar;11(3):426-34. doi: 10.1016/j.hrthm.2013.12.007. Epub 2013 Dec 7.

PMID:
24321235
10.

Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.

Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC.

Circulation. 2013 Aug 27;128(9):944-53. doi: 10.1161/CIRCULATIONAHA.113.003042.

11.

Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.

Köbe J, Reinke F, Meyer C, Shin DI, Martens E, Kääb S, Löher A, Amler S, Lichtenberg A, Winter J, Eckardt L.

Heart Rhythm. 2013 Jan;10(1):29-36. doi: 10.1016/j.hrthm.2012.09.126. Epub 2012 Sep 29.

PMID:
23032867
12.

Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.

Griksaitis MJ, Rosengarten JA, Gnanapragasam JP, Haw MP, Morgan JM.

Europace. 2013 Apr;15(4):523-30. doi: 10.1093/europace/eus388. Epub 2013 Jan 20.

PMID:
23333943
13.

Clinical experience with a novel subcutaneous implantable defibrillator system in a single center.

Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L.

Clin Res Cardiol. 2011 Sep;100(9):737-44. doi: 10.1007/s00392-011-0303-6. Epub 2011 Mar 17.

14.

Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.

Koman E, Gupta A, Subzposh F, Saltzman H, Kutalek SP.

J Interv Card Electrophysiol. 2016 Mar;45(2):219-23. doi: 10.1007/s10840-015-0093-2. Epub 2016 Jan 14.

PMID:
26768264
15.

High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?

Osswald BR, De Simone R, Most S, Tochtermann U, Tanzeem A, Karck M.

Eur J Cardiothorac Surg. 2009 Mar;35(3):489-92. doi: 10.1016/j.ejcts.2008.10.021. Epub 2009 Jan 14.

PMID:
19144533
16.

Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.

Kuschyk J, Stach K, Tülümen E, Rudic B, Liebe V, Schimpf R, Borggrefe M, Röger S.

Heart Rhythm. 2015 Nov;12(11):2230-8. doi: 10.1016/j.hrthm.2015.06.022. Epub 2015 Jun 12.

PMID:
26073595
17.

Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.

Arnson Y, Suleiman M, Glikson M, Sela R, Geist M, Amit G, Schliamser JE, Goldenberg I, Ben-Zvi S, Orvin K, Rosenheck S, Adam Freedberg N, Strasberg B, Haim M.

Heart Rhythm. 2014 May;11(5):814-21. doi: 10.1016/j.hrthm.2014.01.030. Epub 2014 Jan 30.

PMID:
24486799
18.

Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.

Sanghera R, Sanders R, Husby M, Bentsen JG.

Ann N Y Acad Sci. 2014 Nov;1329:1-17. doi: 10.1111/nyas.12550. Epub 2014 Oct 10. Review.

PMID:
25308791
19.

[Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].

Lelakowski J, Rydlewska A, Piekarz J, Lelakowska-Pieła M, Pudło J.

Pol Merkur Lekarski. 2016 Mar;40(237):153-9. Polish.

PMID:
27088195
20.

Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.

Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, Arora R, Chicos AB, Kim SS, Lin AC, Passman RS, Knight BP.

Heart Rhythm. 2014 Aug;11(8):1361-6. doi: 10.1016/j.hrthm.2014.04.025. Epub 2014 Apr 19.

PMID:
24755323

Supplemental Content

Support Center